Viral HIV integrase inhibitor is:
**Core Concept**
The question is testing the student's knowledge of antiretroviral therapy (ART) for HIV, specifically the class of drugs known as integrase strand transfer inhibitors (INSTIs). These medications work by inhibiting the HIV integrase enzyme, which is essential for the integration of viral DNA into the host cell's genome.
**Why the Correct Answer is Right**
Raltegravir is a viral HIV integrase inhibitor that targets the integrase enzyme, preventing the integration of viral DNA into the host cell's genome. By inhibiting this step in the viral life cycle, raltegravir reduces the replication of HIV and slows disease progression. This mechanism of action is unique to INSTIs and differentiates them from other classes of antiretroviral medications.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not a viral HIV integrase inhibitor.
**Option B:** This option is not a viral HIV integrase inhibitor.
**Option C:** This option is not a viral HIV integrase inhibitor.
**Clinical Pearl / High-Yield Fact**
INSTIs like raltegravir have been shown to be effective in reducing viral loads and improving clinical outcomes in patients with HIV. They are often used in combination with other antiretroviral medications to achieve optimal suppression of the virus.
**Correct Answer: C. Raltegravir**